Selected article for: "action mechanism and macrophage polarization"
Author: Li, Dongbo; Ji, Hongfei; Niu, Xingjian; Yin, Lei; Wang, Yiran; Gu, Yucui; Wang, Jinlu; Zhou, Xiaoping; Zhang, Han; Zhang, Qingyuan
Title: Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer
  • Document date: 2019_12_19
    • ID: yj9mb88g_5
    Snippet: CM from tamoxifen-sensitive and -resistant breast cancer cells was tested for its ability to induce macrophage M2 polarization. We then examined the role of TAM in promoting tamoxifen resistance. We also identified a specific cytokine, CCL2, secreted by TAM to promote endocrine resistance and investigated its underlying mechanism of action. CCL2 immunohistochemistry was carried out on pathological sections from patients with invasive ER-positive .....
    Document: CM from tamoxifen-sensitive and -resistant breast cancer cells was tested for its ability to induce macrophage M2 polarization. We then examined the role of TAM in promoting tamoxifen resistance. We also identified a specific cytokine, CCL2, secreted by TAM to promote endocrine resistance and investigated its underlying mechanism of action. CCL2 immunohistochemistry was carried out on pathological sections from patients with invasive ER-positive breast cancer to examine the correlation between CCL2 expression and disease prognosis. Our findings will further the understanding of how TAM promote tamoxifen resistance in breast cancer cells and may identify novel therapeutic targets for patients with endocrine-resistant breast cancer.

    Search related documents:
    Co phrase search for related documents
    • cancer cell and endocrine resistance: 1
    • cancer cell and endocrine resistant breast cancer: 1
    • cancer cell and ER positive breast cancer: 1, 2, 3
    • cancer cell and TAM role: 1, 2
    • cancer cell and tamoxifen resistance: 1
    • disease prognosis and therapeutic target: 1, 2, 3, 4, 5, 6
    • endocrine resistance and ER positive breast cancer: 1, 2, 3
    • endocrine resistance and invasive ER positive breast cancer: 1
    • endocrine resistance and TAM role: 1
    • endocrine resistance and tamoxifen resistance: 1, 2, 3, 4
    • endocrine resistance promote and ER positive breast cancer: 1
    • endocrine resistance promote and invasive ER positive breast cancer: 1
    • endocrine resistant breast cancer and ER positive breast cancer: 1
    • endocrine resistant breast cancer and invasive ER positive breast cancer: 1
    • ER positive breast cancer and invasive ER positive breast cancer: 1
    • ER positive breast cancer and tamoxifen resistance: 1, 2, 3
    • ER positive breast cancer and therapeutic target: 1
    • specific cytokine and therapeutic target: 1, 2, 3, 4
    • TAM role and tamoxifen resistance: 1